Author Archives: Reuters News Agency

Missing people presumed dead after Norway landslide, police chief says

OSLO (Reuters) – Norwegian rescue workers gave up hope on Tuesday of finding more survivors from a Dec. 30 landslide that swept away a dozen buildings but vowed to continue the search for three people who are still missing.

Seven men, women and children have so far been found dead after a landslide struck a residential area in the municipality of Gjerdrum, some 30 km (19 miles) north of the capital, Oslo.

“While we no longer have hope of finding survivors, we’re not ending the search,” police chief Ida Melbo Oeystese told a news conference.

Police and other rescue workers used dogs, drones and helicopters, including heat-seeking equipment, to search for survivors in the debris.

The landslide and the rescue effort have gripped the Nordic nation of 5.4 million, but with temperatures well below freezing, the hope of finding anyone alive had rapidly faded.

(Reporting by Terje Solsvik; Editing by Bernadette Baum)

China doubles down on COVID narrative as WHO investigation looms

By David Stanway

SHANGHAI (Reuters) – As a team from the World Health Organization (WHO) prepares to visit China to investigate the origins of COVID-19, Beijing has stepped up efforts not only to prevent new outbreaks, but also shape the narrative about when and where the pandemic began.

China has dismissed criticism of its early handling of the coronavirus, first identified in the city of Wuhan at the end of 2019, and foreign ministry spokeswoman Hua Chunying said on Monday that the country would welcome the WHO team.

But amid simmering geopolitical tensions, experts said the investigators were unlikely to be allowed to scrutinize some of the more sensitive aspects of the outbreak, with Beijing desperate to avoid blame for a virus that has killed more than 1.8 million people worldwide.

“Even before this investigation, top officials from both sides have been very polarized in their opinions on the origins of the outbreak,” said Yanzhong Huang, senior fellow with the Council on Foreign Relations, a U.S. think tank.

“They will have to be politically savvy and draw conclusions that are acceptable to all the major parties,” he added.

While other countries continue to struggle with infection surges, China has aggressively doused flare-ups. After a new cluster of cases last week, the city of Shenyang sealed off entire communities and required all non-essential workers to stay home.

On Saturday, senior diplomat Wang Yi praised the anti-pandemic efforts, saying China not only curbed domestic infections, but also “took the lead in building a global anti-epidemic defense” by providing aid to more than 150 countries.

But mindful of the criticism China has faced worldwide, Wang also became the highest-ranking official to question the consensus about COVID-19’s origins, saying “more and more studies” show that it emerged in multiple regions.

China is also the only country to claim COVID-19 can be transmitted via cold chain imports, with the country blaming new outbreaks in Beijing and Dalian on contaminated shipments – even though the WHO has downplayed those risks.

TRANSPARENCY

China has been accused of a cover-up that delayed its initial response, allowing the virus to spread further.

The topic remains sensitive, with only a handful of studies into the origins of COVID-19 made available to the public.

But there have also been signs China is willing to share information that contradicts the official picture.

Last week, a study by China’s Center for Disease Control showed that blood samples from 4.43% of Wuhan’s population contained COVID-19 antibodies, indicating that the city’s infection rates were far higher than originally acknowledged.

But scientists said China must also share any findings suggesting COVID-19 was circulating domestically long before it was officially identified in December 2019.

An Italian study showed that COVID-19 might have been in Europe several months before China’s first official case. Chinese state media used the paper to support theories that COVID-19 originated overseas and entered China via contaminated frozen food or foreign athletes competing at the World Military Games in Wuhan in October 2019.

Raina MacIntyre, head of the Kirby Institute’s Biosecurity Research Program in Australia, said the investigation needed to draw “a comprehensive global picture of the epidemiological clues”, including any evidence COVID-19 was present outside of China before December 2019.

However, political issues mean they are unlikely to be given much leeway to investigate one hypothesis, that the outbreak was caused by a leak at the Wuhan Institute of Virology, said MacIntyre.

“I think it is unlikely all viruses in the lab at the time will be made available to the team,” she said. “So I do not think we will ever know the truth.”

Why the winners in Georgia runoffs might not be known for days

By Jason Lange and Brad Heath

(Reuters) – The outcome of two Senate runoff races in Georgia might not be known for days after polls close on Tuesday.

Public opinion polls show Republican incumbents Kelly Loeffler and David Perdue have about the same level of support as their Democratic challengers Raphael Warnock and Jon Ossoff.

Following are key facts on the vote-counting process and what to expect as election returns start to come in Tuesday night.

WHY MIGHT THIS DRAG ON?

Slow counting of Georgia’s mail ballots in November’s presidential election kept the world in the dark about who won the state until three days after polls closed. Biden ended up winning the state by less than 12,000 votes out of about 5 million cast.

A similar delay could unfold after Tuesday’s contests if the races are really close, said Walter Jones, a spokesman for the office of Georgia’s top election official, Secretary of State Brad Raffensperger.

“We may be looking at several days,” Jones said, adding that the delay would mostly come from mail ballots returned on Election Day.

Election officials cannot start counting ballots until 7 p.m. on Tuesday, though they have started processing them, such as checking that voter signatures on mail ballots match those on record.

Nearly 1 million mail-in ballots have been processed through Sunday, state data shows. These ballots, as well as more than 2 million cast in person at early voting centers, will likely be counted quickly on Election Night.

But for the mail votes that arrive on Election Day, officials will still need to open envelopes, check signatures and load the ballots in counting machines. They will also need to process hundreds of thousands of votes expected to be cast in person that day.

RED MIRAGE?

In November, mail ballots heavily favored Biden in Georgia and other swing states, while President Donald Trump led in votes cast in person. If more Democrats again vote by mail this time, initial results could similarly show Republicans in a lead that gives way to Democrats catching up.

The slow counting of mail ballots was a key reason why Trump took an early lead on Election Night on Nov. 3, only to trail Biden in the days that followed as more mail ballots were counted.

In the end, about a quarter of Georgia’s ballots in November were cast by mail and Biden won about two-thirds of them, state data shows. The rest were cast in person, with about 55% going to Trump.

“Initial results will generally reflect the state of the race but probably will be a little redder than what they will end up being,” said Kyle Kondik, a political analyst at the University of Virginia’s Center for Politics.

RECOUNTS

Georgia did two recounts of November’s presidential contest: a hand recount of paper ballots ordered by the state’s top election official, and a subsequent recount using computer scanners that was requested by the Trump campaign.

Georgia allows a losing candidate to force a recount if the margin of victory is less than or equal to 0.5% of the total vote in the race. A recount must be requested within two days of the results being certified by election officials.

Candidates can also request a recount if they think there has been an error in the tabulation; in that case it’s up to the secretary of state to decide whether to conduct one. Local election officials also have the power to recount results in their county before the results are certified.

(Reporting by Jason Lange and Brad Heath; Editing by Soyoung Kim and Dan Grebler)

New York finds first case of more contagious, ‘UK’ strain of coronavirus

(Reuters) – New York Governor Andrew Cuomo says his state has found its first case of the more contagious, “UK” strain of the coronavirus, raising concerns about threats to hospital capacity should it spread rapidly in the state.

Cuomo says on Monday that a man in his 60’s living in a town north of Albany has the new strain. The man, who is recovering, had not traveled recently, suggesting community spread is taking place. New York has carried out 5,000 tests for the new strain – and so far has only found the one case. Cuomo says it could be a “game changer” if the new strain increases hospitalizations and forces regions to close down.

(Reporting by Brad Brooks, Editing by Franklin Paul)

Pediatric use of COVID-19 antibody drugs not advised by experts; disinfectant use can cause asthma flares

By Nancy Lapid

(Reuters) – The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus.

Experts advise against antibody drugs in pediatric COVID-19

As of now, antibody therapies for COVID-19 should not be used to treat infections with the new coronavirus in children or adolescents, “including those … at high risk of progression to hospitalization or severe disease,” according to a panel of experts from 29 hospitals across North America who reviewed the available evidence. The antibody drugs – bamlanivimab from Eli Lilly and Co and the combination of casirivimab plus imdevimab from Regeneron Pharmaceuticals Inc – were authorized in November by the U.S Food and Drug Administration for emergency use in certain groups of adolescents and adults with mild-to-moderate COVID-19. But in a paper published on Sunday in the Journal of the Pediatric Infectious Diseases Society, the panel of experts said: “The course of COVID-19 in children and adolescents is typically mild and there is no high-quality evidence supporting any high risk groups. There is no evidence for safety and efficacy of monoclonal antibody therapy for treatment of COVID-19 in children or adolescents, limited evidence of modest benefit in adults, and evidence for potential harm.” (https://bit.ly/3b2kVyG)

Disinfecting during pandemic puts asthmatics at risk

Increased cleaning by people with asthma during the pandemic may be triggering flares of their disease, a new report suggests. Researchers who surveyed 795 U.S. adults with asthma between May and September found the proportion who disinfected surfaces with bleach at least five times a week rose by 155% after the pandemic started. Use of disinfectant wipes, sprays, and other liquids also increased, the researchers reported in Journal of Allergy & Clinical Immunology: In Practice. After accounting for other behaviors and risk factors, higher odds of having uncontrolled asthma were linked with greater household use of disinfectant wipes, disinfectant sprays, bleach and water solutions, and other disinfecting liquids. The study does not prove that increased frequency of disinfecting caused uncontrolled asthma. Still, the authors say, people with asthma need safer cleaning options. The U.S. Centers for Disease Control and Prevention advises asthmatics to ask someone else to clean and disinfect surfaces and to stay in another room when cleaners or disinfectants are used and right afterward. It also said soap and water may be sufficient for surfaces and objects that are seldom touched.

News reports paint overly rosy picture of blood treatment

News reports about critically ill COVID-19 patients treated with a last-ditch procedure known as extracorporeal membrane oxygenation, or ECMO, may be painting an unrealistic picture of outcomes, a study suggests. During ECMO, blood is pumped outside of the body through a machine that removes carbon dioxide and adds oxygen before returning the blood back to the body. In a review of media reports about ECMO treatment of COVID-19, doctors found that 92% of patients in the stories survived, whereas average survival rates after ECMO in large studies have ranged from 53% in children to 63% in young and middle-aged adults. Patients receiving the ECMO treatment “remain at substantial risk” of complications and death, but most news reports of COVID-19 patients treated with ECMO did not address these risks, the researchers said on Monday in JAMA Internal Medicine. They say recognition of the exaggerated benefit suggested by media reports may help intensive care unit doctors, patients and families have more realistic discussions about prognosis after ECMO.

(Reporting by Nancy Lapid; Editing by Bill Berkrot)

New York, Florida tell hospitals to speed COVID-19 vaccinations or lose supply

By Carl O’Donnell and Jonathan Allen

NEW YORK (Reuters) – The governors of New York and Florida sought to accelerate the slower-than-expected rollout of coronavirus vaccines by warning hospitals on Monday that they would reduce future allocations to those that fail to dispense shots quickly enough.

In New York, hospitals must administer vaccines within a week of receiving them or face a fine and loss of future supplies, Governor Andrew Cuomo said.

“I don’t want the vaccine in a fridge or a freezer, I want it in somebody’s arm,” the governor said. “If you’re not performing this function, it does raise questions about the operating efficiency of the hospital.”

The U.S. federal government has distributed more than 15 million vaccine doses to states and territories around the country, but only around 4.5 million have been administered so far, according to data from the U.S. Centers for Disease Control and Prevention (CDC) released on Monday.

The U.S. government has fallen far short of its target of vaccinating 20 million people by the end of 2020. Officials said they expect the rollout will pick up significantly this month.

Surgeon General Jerome Adams told CBS News that there are 15 million to 20 million doses of vaccine available.

“We should be hopeful about that while acknowledging we have got to do better and we are going to keep doing better,” Adams said. “And I promise you, you will see in these next two weeks numbers increase substantially.”

The United States had reported a total of 20.5 million COVID-19 cases and 351,480 deaths as of midnight on Sunday. On a seven-day rolling average, it is reporting 210,190 cases and 2,636 coronavirus deaths per day.

In Florida, where officials have put senior citizens ahead of many essential workers for getting the vaccine, Governor Ron DeSantis announced a policy under which the state would allocate doses to hospitals that dispense them most quickly,

“Hospitals that do not do a good job of getting the vaccine out will have their allocations transferred to hospitals that are doing a good job at getting the vaccine out,” DeSantis said at a briefing.

“We do not want vaccine to just be idle at some hospital system,” he added, though he did not say they would face fines.

Florida will also deploy an additional 1,000 nurses to administer vaccines and will keep state-run vaccination sites open seven days a week, he said.

New York has dispensed about 175,000 doses of the 896,000 it has received since mid-December, according to CDC data. Florida has dispensed 265,000 of the 1.14 million doses it received.

In New York City, Mayor Bill de Blasio said obstacles were slowing his goal to have 1 million residents receive a first of two vaccine doses by the end of January. A little over 110,000 residents have received their first dose so far, according to city data.

De Blasio urged the state to broaden early eligible groups beyond healthcare workers and nursing home residents to include essential workers such as teachers, police officers, fire fighters, grocery store personnel and people who are more than 75 years old.

New York City currently has 125 vaccination sites and plans to double that by the end of the month, the mayor said.

“This has got to be a seven-day-a-week, 24-hour reality going forward,” de Blasio said.

Monday also marked the first day when some Americans were due to receive their second vaccine shot, three weeks after getting the first dose. Among them was Maritza Beniquez, a healthcare worker in Newark, New Jersey.

“I now have body armor,” she said after receiving the dose in a video posted on Facebook by New Jersey Governor Phil Murphy, who was part of a small gathering that witnessed the event.

(Reporting by Jonathan Allen, Carl O’Donnell, Rebecca Spaulding and Peter Szekely in New York; Additional reporting by Barbara Goldberg, Anurag Maan, Doina Chiacu and Susan Heavey; Editing by Bill Berkrot)

England goes into new COVID-19 lockdown as cases surge

By William Schomberg and Elizabeth Piper

LONDON (Reuters) – British Prime Minister Boris Johnson on Monday ordered England into a new national lockdown to try to slow a surge in COVID-19 cases that threatens to overwhelm parts of the health system before a vaccine program reaches a critical mass.

Johnson said a new, more contagious variant of the coronavirus was spreading at great speed and urgent action was needed to slow it down.

“As I speak to you tonight, our hospitals are under more pressure from COVID than any time since the start of the pandemic,” Johnson said in a televised address to the country as he ditched his regional approach to fighting the pandemic.

“With most of the country already under extreme measures, it’s clear that we need to do more together to bring this new variant under control.

“We must therefore go into a national lockdown, which is tough enough to contain this variant. That means the government is once again instructing you to stay at home.”

Johnson said the measures would include school closures from Tuesday and rules requiring most people to stay at home apart from essential shopping, exercise and other limited exceptions.

He said that if the timetable of the vaccination program went as planned and the number of cases and deaths responded to the lockdown measures as expected, it should be possible to start moving out of lockdown by the middle of February.

However, he urged caution about the timetable.

NEW VACCINE LAUNCHED

As Britain grapples with the world’s sixth highest death toll and cases hit a new high, the country’s chief medical officers said the spread of COVID-19 risked overwhelming parts of the health system within 21 days.

The surge in cases has been driven by the new variant of COVID-19, officials say, and while they acknowledge that the pandemic is spreading more quickly than expected, they say there is also light at the end of the tunnel – vaccinations.

Johnson’s government earlier touted a scientific “triumph” as Britain became the first country in the world to start vaccinating its population with Oxford University and AstraZeneca’s COVID-19 shot.

Dialysis patient Brian Pinker on Monday received the first vaccination outside of a trial.

“I am so pleased to be getting the COVID vaccine today and really proud that it is one that was invented in Oxford,” said the 82-year-old retired maintenance manager, just a few hundred meters from where the vaccine was developed.

But even with the vaccines being rolled out, the number of COVID-19 cases and deaths keep rising.

More than 75,000 people in the United Kingdom have died from COVID-19 within 28 days of a positive test since the start of the pandemic. A record 58,784 new cases of the coronavirus were reported on Monday.

Moving a few hours ahead of Johnson, Scottish First Minister Nicola Sturgeon imposed the most stringent lockdown for Scotland since last spring.

The devolved administration in Wales said all schools and colleges there should move to online learning until Jan. 18.

(Additional reporting by Estelle Shirbon, Alistair Smout and Guy Faulconbridge; Editing by Gareth Jones)

In deadliest week so far, U.S. loses more than 18,400 lives to COVID-19

(Reuters) – December was the deadliest month of the coronavirus pandemic in the United States with nearly 78,000 deaths, and health officials warned that even more people will likely die in January despite the rollout of vaccines.

In the week ended Jan. 3, more than 18,400 people died from COVID-19, bringing the pandemic’s total to over 351,000 deaths, or one in every 930 U.S. residents, according to a Reuters analysis of state and county reports.

The country reported nearly 1.5 million new infections last week, up 16.5% from the previous seven days.

Many testing centers were closed for the year-end holiday, likely reducing the number of cases reported last week. Health officials have warned that figures this week may be abnormally high due to a backlog of data.

More than 126,000 COVID-19 patients are currently in hospitals, up 25% from one month ago. The rise in hospitalizations, which have hit new records almost every day in recent weeks, is the main reason health experts predict further increases in deaths in coming weeks.

Despite pleas to avoid traveling for the holidays, U.S. airports screened 1.3 million people on Sunday, the highest since mid-March.

Arizona, Tennessee and South Carolina reported the most new cases per capita last week, according to the Reuters analysis. In terms of deaths per capita, Kansas, Wyoming and New Mexico were the hardest hit last week.

Across the United States, 13.6% of tests came back positive for the virus, up from 10.3% the prior week, according to data from the volunteer-run COVID Tracking Project. The highest rates were in Iowa at 64%, Idaho at 56% and Alabama at 47%.

The World Health Organization considers positive test rates above 5% concerning because it suggests there are more cases in the community that have not yet been uncovered.

(Graphic by Chris Canipe, writing by Lisa Shumaker, editing by Tiffany Wu)

15.4 million doses of COVID-19 vaccines distributed, 4.5 million administered: U.S. CDC

(Reuters) – The U.S. Centers for Disease Control and Prevention said it had administered 4,563,260 first doses of COVID-19 vaccines in the country as of Monday morning and distributed 15,418,500 doses.

The tally of vaccine doses distributed and the number of people who received the first dose are for both Moderna and Pfizer/BioNTech, vaccines as of 9:00 a.m. ET on Saturday, the agency said.

According to the tally posted on Jan. 2, the agency had administered 4,225,756 first doses of the vaccines and distributed 13,071,925 doses.

A total of 2,533,925 vaccine doses were distributed for use in long-term care facilities and 365,294 people in the facilities got their first dose, the agency said.

The agency also reported 20,558,489 cases of the coronavirus, an increase of 212,117 cases from its previous count, and said that the number of deaths had risen by 1,418 to 350,664.

The CDC reported its tally of cases of the respiratory illness known as COVID-19, caused by a new coronavirus, as of 4 p.m. ET on Jan. 3 versus its previous report a day earlier.

The CDC figures do not necessarily reflect cases reported by individual states.

(Reporting by Vishwadha Chander in Bengaluru; Editing by Amy Caren Daniel)

Breakthrough reached in Gulf dispute with Qatar: senior Trump administration official

By Steve Holland

WASHINGTON (Reuters) – A breakthrough has been reached in Qatar’s three-year-old dispute with Saudi Arabia and three other Arab countries and an agreement to end their rift is to be signed in Saudi Arabia on Tuesday, a senior Trump administration official said.

“We’ve had a breakthrough in the Gulf Cooperation Council rift,” said the official, who spoke to Reuters on condition of anonymity.

The development is the latest in a series of Middle East deals sought by Washington – the others involving Israel and Arab states – aimed at building a united front against Iran. All of the countries involved in the deals are U.S. allies.

White House senior adviser Jared Kushner, assigned to work on the dispute by U.S. President Donald Trump, helped negotiate the deal and was working the phones on it until the wee hours of Monday morning, the official said.

When in December, Saudi Arabia’s foreign minister said a resolution to the dispute seemed within reach, Iran’s Foreign Minister Mohammad Javad Zarif in a Twitter post said he hoped Gulf reconciliation “contributes to stability and political and economic development for all peoples of our region.”

Saudi Arabia, the United Arab Emirates, Bahrain and Egypt have imposed a diplomatic, trade and travel embargo on Qatar since mid-2017 accusing it of supporting terrorism. Qatar denies it and says the embargo aims to undermine its sovereignty.

Kushner, joined by Middle East envoy Avi Berkowitz and Brian Hook, a special State Department adviser, were flying to the Saudi Arabian city of al-Ula to attend the ceremony, the official said.

Gulf Arab leaders are expected to gather in Saudi Arabia on Tuesday for an annual summit that is expected to announce a deal towards ending the rift.

Under the emerging agreement, the four countries will end the blockade of Qatar, and in exchange, Qatar will not pursue lawsuits related to the blockade, the official said.

“At the signing on the 5th, leadership from the Gulf Cooperation Council plus Egypt will be coming together to sign an agreement that will end the blockade and put an end to the Qatari lawsuits,” the official said.

If the deal holds, the Gulf dispute will be added to a string of diplomatic victories achieved by the Kushner team, a list that includes normalization deals last year between Israel and the United Arab Emirates, Bahrain, Sudan and Morocco.

“It’s just a massive breakthrough,” the official said. “The blockade will be lifted. It will allow for travel amongst the countries as well as goods. It will lead to more stability in the region.”

(Reporting by Steve Holland; Editing by Howard Goller)